Challenges in Prostate Cancer, 2nd Edition
June 2006, Wiley-Blackwell
Challenges in prostate cancer provides a series of state-of-the-art review articles, each of which addresses and answers a contentious question. It includes chapters on medical and surgical management of all stages of prostate cancer, clinical investigation, epidemiology, clinical trials and basic scientific research and covers issues such as the genetic basis of cancer, clinical economics and influence.
The authors have used their expertise to distil the available evidence into practical advice to be used by busy urologists in their day-to-day practice. And as well as being an overview of current practice many chapters attempt to give insights into the future direction of prostate cancer research and clinical management.
1 An Update on Biotechnology in the Assessment of Prostate Cancer.
2 What Can We Learn From Breast Cancer?.
3 New Serum Markers for Prostate Cancer.
4 The History of Tissue Recombination Technology: Current and Future Research.
5 Why We Cannot Use the Results of Non-Randomised Trials to Inform Us About Treatment for Early Prostate Cancer?.
Part 2: Diagnosis and Evaluation.
6 Equivocal PSAResults and Free Total PSARatio.
7 Equivocal Prostate Needle Biopsies.
8 Prostate Biopsy: How Many Cores and Where From?.
9 Counselling Patients With Early Prostate Cancer.
10 The Role of Pelvic Node Dissection in Prostate Cancer.
Part 3: Initial Treatment Policies.
11 Laparoscopic Radical Prostatectomy.
12 Endocrine Therapy for Prostate Cancer: the Latest.
13 The Role of Conservative Policies in the Treatment of Prostate Cancer.
14 Complementary and Alternative Therapies for Prostate Cancer.
Part 4: Monitoring Progress and SecondaryTreatment.
15 Radical Prostatectomy After Radical Radiotherapy.
16 Treatment of Renal Impairment Secondary to Locally Advanced Prostate Cancer.
17 Open Radical Prostatectomy: How Can Intra-operative, Peri-operative and Post-operative Complications Be Prevented?.
18 Documenting Prostate Cancer: Epidemiology and Treatment.
19 Trends in Prostate Cancer Incidence and Mortality.
20 Chemotherapy in Prostate Cancer.
Adam Carter, Department of Urology, Royal Gwent Hospital, Newport
Prostate cancer is a major and rising threat to men’s health
Contains collected review articles covering diagnosis and management
Also covers issues such as the genetic basis of cancer, clinical economics and influence
British Journal of Urology
"...contains useful information and is a helpful resource for understanding many of the controversies in this area."